Jane A Gross - Net Worth and Insider Trading

Jane A Gross Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jane A Gross owns 3 companies in total, including Aptevo Therapeutics Inc (APVO) , aTyr Pharma Inc (ATYR) , and BriaCell Therapeutics Corp (BCTX) .

Click here to see the complete history of Jane A Gross’s form 4 insider trades.

Insider Ownership Summary of Jane A Gross

Ticker Comapny Transaction Date Type of Owner
APVO Aptevo Therapeutics Inc 2016-09-01 See Remarks
ATYR aTyr Pharma Inc 2019-06-28 director
BCTX BriaCell Therapeutics Corp 2022-08-01 director

Jane A Gross Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jane A Gross Ownership Network

Ownership Network List of Jane A Gross

No Data

Ownership Network Relation of Jane A Gross

Insider Network Chart

Jane A Gross Owned Company Details

What does Aptevo Therapeutics Inc do?

Who are the key executives at Aptevo Therapeutics Inc?

Jane A Gross is the See Remarks of Aptevo Therapeutics Inc. Other key executives at Aptevo Therapeutics Inc include SVP & CFO Daphne Taylor , 10 percent owner Kevin C Tang , and See Remarks Soyoung Kwon .

Aptevo Therapeutics Inc (APVO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aptevo Therapeutics Inc (APVO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aptevo Therapeutics Inc (APVO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aptevo Therapeutics Inc (APVO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Aptevo Therapeutics Inc Insider Transactions

No Available Data

Jane A Gross Mailing Address

Above is the net worth, insider trading, and ownership report for Jane A Gross. You might contact Jane A Gross via mailing address: 2401 4th Avenue, Suite 1050, Seattle Wa 98121.

Discussions on Jane A Gross

No discussions yet.